Sodium monomercaptoundecahydro-closo-dodecaborate

Sodium monomercaptoundecahydro-closo-dodecaborate
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 1984-12-18 00:00:00
Sponsor Theragenics Corporation;;
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM